Skip to contentA
Abbott Laboratories
A
ABTAbbott Laboratories Q1 2017 · 10-Q
Revenue$6.34B$6.34B+29.7% vs Q1 2016 Net Income$419.00M$419.00M+32.6% vs Q1 2016 EPS Diluted$0.24$0.24+14.3% vs Q1 2016 Gross Profit$2,751,000,000+5.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
Operating Cash Flow$574,000,000N/M Free Cash Flowderived$302,000,000N/M Margins · derivedGross margin43.4%−9.8 pt vs Q1 2016
Operating margin-3.8%−14.5 pt vs Q1 2016
Net margin6.6%+0.1 pt vs Q1 2016
ended Mar 31, 2017 · filed May 3, 2017 · 33 d after period end